focus -WSS

focus

author：Wikipedia 2025-09-27 06:03:18 - browse：68436

Dr. Laurie Glimcher, CEO of Dana Farber Cancer Institute, opens both arms while talking — coverage from STAT — Laurie Glimcher, CEO of Dana Farber Cancer Institute, is the architect of the biggest shakeup in Boston health care in decades. David L. Ryan/Globe Staff

Dr. Laurie Glimcher learned early on from her father, a prominent physician-researcher, that success in science was built on a basic principle: Big discoveries require big risks.

The younger Glimcher took that advice to heart. In the late 1990s at her Harvard immunology lab, Glimcher and her postdoctoral student began a series of experiments that colleagues deemed “crazy.” But after a year of trial and error, the lab had a eureka moment when it found that white blood cells could be reprogrammed, a seminal discovery that led to new ways to treat cancer.

“Most scientists do good work, but they don’t transform a scientific question,” said Glimcher. “I always felt the only way to do that is to think big and go after something that’s going to be really important.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Senate committee advances SCOTUS ethics bill after alleged justice misconduct

focus

WSS

Jury awards Florida girl burned by McDonald's Chicken McNugget $800,000 in damages

DeSantis can now import cheaper drugs. But will Biden get credit?

Winning ticket for $1 billion Powerball jackpot sold in California

7 more heat

Texas Department of Public Safety speaks out on migrant abuse allegations

Affordable Connectivity Program vital to health care, experts say

focus

focus

focus

Apple is now the first public company to be valued at $3 trillion

Biotech reporter’s notebook: A sunnier mood at JPM 2024

Duchenne breakthrough therapy leaves behind pioneering families

The nurse manager staffing crisis is hurting patients

Supreme Court strikes down use of affirmative action

Stanford president faces new allegations over 1999 paper

Cancer drug shortages should be causing more outrage

7 more heat

Wildfire smoke exposes gaps in outdoor worker protections

Awakening the world to the whoosh: A patient's crusade

explore

Biotech reporter’s notebook: A sunnier mood at JPM 2024

The SUPPORT Act is critical to fighting the opioid crisis

DeSantis talks Trump, trans issues and 'what wokeness is'

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

DeSantis can now import cheaper drugs. But will Biden get credit?

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

hotspot

focus

explore

leisure time